Integrated proteomic and phosphoproteomic profiling unravels an O‐ GlcNAc ‐dependent mechanism in DGAT1 inhibition‐mediated protection of β‐cells from lipotoxicity

Documenti analoghi

• Renal lipotoxicity in diabetic and obesity‐associated kidney diseases: Molecular mechanisms and therapeutic targeting
  di: Qing Liu, et al.
  Pubblicazione: (2025)
• Deletion of RalGAP β protects pancreatic β cells and improves glycemic control
  di: Weikuan Feng, et al.
  Pubblicazione: (2025)
• Plasma proteomics identifies potential drug targets for diabetic polyneuropathy: Evidence from prospective cohorts and genetic analysis
  di: Haoning Lan, et al.
  Pubblicazione: (2025)
• Causal relationship between key genes and metabolic dysfunction‐associated fatty liver disease risk mediated by immune cells: A Mendelian randomization and mediation analysis
  di: Gong Feng, et al.
  Pubblicazione: (2024)
• Pancreatic β‐cell turnover in health and disease
  di: Yasmine Alcibahy, et al.
  Pubblicazione: (2025)